Guangdong Jiaying Pharmaceutical Co Ltd Net Asset Momentum
Guangdong Jiaying Pharmaceutical Co Ltd net asset momentum. Guangdong Jiaying Pharmaceutical Co Ltd (002198) recorded a net asset momentum of -5.3% as of December 2025, with net assets of CN¥717.93 Million CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore Guangdong Jiaying Pharmaceutical Co Ltd (002198) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Guangdong Jiaying Pharmaceutical Co Ltd (2004–2025)
Net asset momentum of Guangdong Jiaying Pharmaceutical Co Ltd from 2004 to 2025. This chart tracks Guangdong Jiaying Pharmaceutical Co Ltd's year-over-year net asset growth across 22 annual reporting periods from 2004 to 2025. The most recent momentum reading is -5.3%, with net assets of CN¥717.93 Million CNY as of December 2025. See Guangdong Jiaying Pharmaceutical Co Ltd net assets for net asset value and shareholders' equity analysis.
Guangdong Jiaying Pharmaceutical Co Ltd Net Asset Momentum by Year (2004–2025)
Guangdong Jiaying Pharmaceutical Co Ltd net asset momentum by year from 2004 to 2025. The table below shows the complete annual net asset history for Guangdong Jiaying Pharmaceutical Co Ltd from 2004 to 2025, covering 22 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see market value of Guangdong Jiaying Pharmaceutical Co Ltd.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥717.93 Million | CN¥849.23 Million | CN¥131.30 Million | ▼ -5.3% |
| 2024 | CN¥758.22 Million | CN¥838.82 Million | CN¥80.60 Million | ▼ -0.6% |
| 2023 | CN¥762.98 Million | CN¥847.56 Million | CN¥84.58 Million | ▲ +4.7% |
| 2022 | CN¥728.42 Million | CN¥846.65 Million | CN¥118.23 Million | ▲ +6.4% |
| 2021 | CN¥684.48 Million | CN¥807.34 Million | CN¥122.85 Million | ▲ +0.2% |
| 2020 | CN¥683.01 Million | CN¥808.44 Million | CN¥125.43 Million | ▲ +3.0% |
| 2019 | CN¥663.17 Million | CN¥855.94 Million | CN¥192.77 Million | ▼ -15.6% |
| 2018 | CN¥785.35 Million | CN¥889.56 Million | CN¥104.21 Million | ▲ +4.7% |
| 2017 | CN¥749.81 Million | CN¥876.61 Million | CN¥126.80 Million | ▼ -23.9% |
| 2016 | CN¥984.87 Million | CN¥1.10 Billion | CN¥114.38 Million | ▲ +5.9% |
| 2015 | CN¥929.70 Million | CN¥1.05 Billion | CN¥118.30 Million | ▲ +7.7% |
| 2014 | CN¥863.35 Million | CN¥1.04 Billion | CN¥171.94 Million | ▲ +6.6% |
| 2013 | CN¥809.66 Million | CN¥919.00 Million | CN¥109.35 Million | ▲ +191.2% |
| 2012 | CN¥278.08 Million | CN¥314.25 Million | CN¥36.17 Million | ▲ +2.8% |
| 2011 | CN¥270.51 Million | CN¥306.55 Million | CN¥36.04 Million | ▲ +4.7% |
| 2010 | CN¥258.47 Million | CN¥300.87 Million | CN¥42.40 Million | ▲ +7.1% |
| 2009 | CN¥241.42 Million | CN¥253.33 Million | CN¥11.91 Million | ▲ +6.7% |
| 2008 | CN¥226.35 Million | CN¥235.24 Million | CN¥8.89 Million | ▲ +6.5% |
| 2007 | CN¥212.62 Million | CN¥245.48 Million | CN¥32.85 Million | ▲ +157.3% |
| 2006 | CN¥82.63 Million | CN¥120.05 Million | CN¥37.42 Million | ▲ +28.3% |
| 2005 | CN¥64.39 Million | CN¥91.23 Million | CN¥26.84 Million | ▲ +31.5% |
| 2004 | CN¥48.97 Million | CN¥71.92 Million | CN¥22.95 Million | — |